Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7334
Rank
HK$4.73 B
Marketcap
HK$135.21
Share price
2.05%
Change (1 day)
-49.08%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement